Growth inhibition of cancer cells by co-transfection of diphtheria toxin a-chain gene plasmid with bovine leukemia virus-tax expression vector

Microbiology and Immunology

Volumn 45, Issue 6, 2001, Pages 447-455

  Tana, ^a   Watarai, S ^a   Aida, Y ^a   Tajima, S ^a   Kakidani, H ^a   Onuma, M ^a   Kodama, H ^a  

^a Osaka Prefecture University   (Japan)

Author keywords

Bovine leukemia virus; Diphtheria toxin; Gene therapy; Tax gene

Indexed keywords

ANTINEOPLASTIC AGENT; DIPHTHERIA TOXIN; LUCIFERASE; PBLV LUC1; PLTR DT; PME BLVTAX; TAX PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BOVINE LEUKEMIA VIRUS; CANCER INHIBITION; CONTROLLED STUDY; DIPHTHERIA; EXPRESSION VECTOR; GENE CONSTRUCT; GENE EXPRESSION REGULATION; GENE TRANSFER; GROWTH INHIBITION; HUMAN; LONG TERMINAL REPEAT; NONHUMAN; PLASMID; PROMOTER REGION;

ANIMALS; CELL LINE, TRANSFORMED; COS CELLS; DIPHTHERIA TOXIN; GENE THERAPY; GENES, PX; GENETIC VECTORS; HELA CELLS; HUMANS; LEUKEMIA VIRUS, BOVINE; LUCIFERASES; PLASMIDS; PROMOTER REGIONS (GENETICS); TRANSFECTION;

BOVINAE; BOVINE LEUKEMIA VIRUS;

EID: 0034956681     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2001.tb02644.x     Document Type: Article

References (36)

1. Breast cancer-specific expression of the Candida albicans cytosine deaminase gene using a transcriptional targeting approach
2. Bovine leukemia virus: Molecular biology and epidemiology
3. HIV-regulated diphtheria toxin A chain gene confers long-term protection against HIV type 1 infection in the human promonocytic cell line U937
4. Gene therapy: A new approach for treatment of cancer
5. Mechanisms of human T-cell leukemia virus-induced leukemogenesis
6. Activation of a diphtheria toxin A gene by expression of human immunodeficiency virus-1 Tat and Rev proteins in transfected cells
7. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex vires thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir
8. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter
9. Transmission and propagation in cell culture of virus produced by cells transfected with an infectious molecular clone of bovine leukemia virus
10. Establishment of bovine leukemia virus-producing and -nonproducing B-lymphoid cell lines and their proviral genomes
11. Suppressive effect of liposomes containing DNA coding for diphtheria toxin A-chain on cells transformed with bovine leukemia virus
12. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene
13. Leukemogenesis by bovine leukemia virus: Proviral DNA integration and lack of RNA expression of viral long terminal repeat and 3′ proximate cellular sequences
14. Genomic integration of bovine leukemia provirus and lack of viral RNA expression in the target cells of cattle with different responses to BLV infection
15. In vitro evaluation of mutant HSV-1 thymidine kinases for suicide gene therapy
16. Cationic liposome-mediated expression of HIV-regulated luciferase and diphtheria toxin a genes in HeLa cells infected with or expressing HIV
17. Evaluation of cationic liposomes for delivery of diphtheria toxin A-chain gene to cells infected with bovine leukemia virus
18. Expression of the diphtheria toxin A-chain coding sequence under the control of promoters and enhancers from immunoglobulin genes as a means of directing toxicity to B-lymphoid cells
19. Regulated expression of a diphtheria toxin A-chain gene transfected into human cells: Possible strategy for inducing cancer cells suicide
20. Establishment of B-cell lines from tumor of enzootic bovine leukosis
21. Cell lineage ablation in transgenic mice by cell-specific expression of a toxin gene
22. Diphtheria toxin
23. Suppression of single and double nonsense mutations introduced into the diphtheria toxin A-chain gene: A potential binary system for toxin gene therapy
24. Identification of diphtheria toxin via screening as a potent cell cycle and p53-independent cytotoxin for human prostate cancer therapeutics
25. The 3′ region of bovine leukemia virus genome encodes a trans-activator protein
26. Gene transfer in mammalian cells using liposomes as carriers
27. Prodrug-activating systems in suicide gene therapy
28. The region between amino acids 245 and 265 of the Tax protein of bovine leukemia virus (BLV) restricts transactivation activity via not only BLV enhancer but other retrovirus enhancers
29. DNA transfection of mouse lymphoid cells by the combination of DEAE-dextran-mediated DNA uptake and osmotic shock procedure
30. In vivo antitumor effect of cationic liposomes containing diphtheria toxin A-chain gene on cells infected with bovine leukemia virus
31. Antitumor effect of diphtheria toxin A-chain gene-containing cationic liposomes conjugated with monoclonal antibody directed to tumor-associated antigen of bovine leukemia cells
32. Severe hepatic dysfunction after adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administration
33. The bovine leukemia virus p34 is a transactivator protein
34. Human T-lymphotropic retroviruses
35. Effect gene transfer with less cytotoxicity by means of cationic multilamellar liposomes
36. One molecule of diphtheria toxin fragment A introduced into a cell can kill the cell